CIBC Bancorp USA
UTHR icon

CIBC Bancorp USA’s United Therapeutics UTHR Stock Holding History

CIBC Bancorp USA’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.37M Sell
2,533
-156
-6% -$80.7K ﹤0.01% 1028
2026
Q2 		$1.46M Sell
2,689
-60
-2% -$33.8K ﹤0.01% 1011
2026
Q1 		$1.63M Buy
+2,749
New +$1.37M ﹤0.01% 944
2025
Q3 		$644K Buy
+1,536
New +$517K ﹤0.01% 778

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

CIBC Bancorp USA's UTHR Position: Q3 2026 in Review

CIBC Bancorp USA reduced its United Therapeutics (UTHR) stake by 5.8% in Q3 2026, selling an estimated $80.7K and leaving 2,533 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

CIBC Bancorp USA first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.63M in Q1 2026. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • CIBC Bancorp USA held 2,533 shares of United Therapeutics worth $1.37M as of Q3 2026.
  • CIBC Bancorp USA sold 156 United Therapeutics shares in Q3 2026, an estimated $80.7K.
  • United Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1028 holding.
  • CIBC Bancorp USA first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's United Therapeutics position peaked at $1.63M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.